Why Everyone’s Buzzing About Anthem’s IPO

Anthem Biosciences just pulled off a blockbuster IPO, raising $395 million as investors piled in. Here’s the scoop: with global pharma giants looking to buy less from China, Indian companies like Anthem are suddenly the cool kids on the block. If you’re tracking where the next big pharma moves are, keep an eye on Indian firms—they’re getting a lot of love as supply chains shift. Might be time to check your portfolio for some Indian flavor! #Business #EntrepreneurshipStartup #IPO